id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0275-0010,FDA,FDA-2006-P-0275,"Background Materials re: Citizen Petition from KV Pharmaceutical Company:: Attachment D - Relevant portions of Reply Brief for the Apellants (FDA) at 35, Ranbaxy Labs. Ltd. v. Leavitt, No. 06-5154 (D.C. Cir. July 27, 2006)",Supporting & Related Material,Background Material,2008-12-17T05:00:00Z,2008,12,,,2024-12-05T15:11:22Z,,0,0,090000648045828c
FDA-2006-P-0275-0012,FDA,FDA-2006-P-0275,"Background Materials re: Citizen Petition from KV Pharmaceutical Company:: Attachment A - Ranbaxy Labs. Ltd. v. Leavitt, No. 05-1838, 2006 U.S. Dist. LEXIS 24612, *28-29 (D.D.C. May 1, 2006) appeal pending, No. 06-5154 (D.C. Cir.)",Supporting & Related Material,Background Material,2008-12-17T05:00:00Z,2008,12,,,2024-12-05T15:13:05Z,,0,0,0900006480458290
FDA-2006-P-0275-0008,FDA,FDA-2006-P-0275,"Background Materials re: Citizen Petition from KV Pharmaceutical Company: Attachment C - Relevant portions of Brief for the Apellants (FDA) at 32, Ranbaxy Labs. Ltd. v. Leavitt, No. 06-5154 (D.C. Cir. June 21, 2006)",Supporting & Related Material,Background Material,2008-12-17T05:00:00Z,2008,12,,,2024-12-05T15:09:21Z,,0,0,0900006480458283
FDA-2006-P-0275-0009,FDA,FDA-2006-P-0275,"Background Materials re: Citizen Petition from KV Pharmaceutical Company:: Attachment E - FDA Letter from Gary Buehler, Dir., Office of Generic Drugs, to Tammy McIntire, Apotex Corp. at 2 (Apr. 11, 2006)",Supporting & Related Material,Background Material,2008-12-17T05:00:00Z,2008,12,,,2024-12-05T15:10:31Z,,0,0,090000648045828a
FDA-2006-P-0275-0007,FDA,FDA-2006-P-0275,Citizen Petition from KV Pharmaceutical Company,Other,Citizen Petition,2008-12-17T05:00:00Z,2008,12,2008-12-17T05:00:00Z,,2024-12-05T15:07:54Z,,0,0,0900006480458291
FDA-2006-P-0275-0011,FDA,FDA-2006-P-0275,"Background Materials re: Citizen Petition from KV Pharmaceutical Company:: Attachment B - 2005P-0008, Vol. 1, LET 3",Supporting & Related Material,Background Material,2008-12-17T05:00:00Z,2008,12,,,2024-12-05T15:12:11Z,,0,0,090000648045828e
FDA-2006-P-0275-0006,FDA,FDA-2006-P-0275,Citizen Petition Denial from FDA CDER to KV Pharmaceutical Co,Other,Denial of Petition,2007-12-17T05:00:00Z,2007,12,,,2024-12-05T14:53:49Z,,0,0,090000648045829b
FDA-2006-P-0275-0005,FDA,FDA-2006-P-0275,Letter from FDA CDER to KV Pharmaceutical Co,Other,Letter(s),2007-04-17T04:00:00Z,2007,4,,,2024-12-05T14:52:11Z,,0,0,0900006480458299
FDA-2006-P-0275-0003,FDA,FDA-2006-P-0275,Acknowledgment Letter Correction from FDA DMB to KV Pharmaceutical Company,Other,Correction(s),2006-10-23T04:00:00Z,2006,10,,,2024-12-05T14:47:40Z,,0,0,0900006480458295
FDA-2006-P-0275-0004,FDA,FDA-2006-P-0275,Acknowledgment Letter Correction from FDA DMB to KV Pharmaceutical Company,Other,Correction(s),2006-10-23T04:00:00Z,2006,10,,,2024-12-05T14:49:26Z,,0,0,0900006480458297
FDA-2006-P-0275-0002,FDA,FDA-2006-P-0275,Acknowledgment Letter from FDA DMB to KV Pharmaceutical Company,Other,Acknowledgement Letter/Receipt,2006-10-20T04:00:00Z,2006,10,,,2024-12-05T14:45:50Z,,0,0,0900006480458294
FDA-2006-P-0275-0001,FDA,FDA-2006-P-0275,Acknowledgment Letter from FDA DMB to KV Pharmaceutical Company,Other,Acknowledgement Letter/Receipt,2006-10-20T04:00:00Z,2006,10,,,2024-12-05T14:42:16Z,,0,0,0900006480458263